Dr. Lisa Larkin addresses one of the most common—and misunderstood—questions in midlife women’s health: does hormone therapy increase the risk of breast cancer? In this evidence-based session, Dr. Larkin will walk through the latest data on menopausal hormone therapy (MHT), explain how risk is communicated (and often misinterpreted), and help women understand what the research really shows. You’ll gain clarity on individualized risk assessment, how different types of MHT impact breast cancer risk, and how to make informed decisions that reflect your personal health history and goals.

Lisa Larkin, MD, FACP, MSCP, IF, is a board-certified internist, certified menopause practitioner, and nationally recognized expert in midlife women’s health. She is the founder of HERmedicine and Ms.Medicine, and a leading voice in advancing personalized, evidence-based care for women. Known for her ability to translate complex science into actionable information, Dr. Larkin is passionate about empowering women to make informed decisions about their health, including hormone therapy, cancer risk, and preventive care.